Cyteir Therapeutics, Inc.
CYTDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001662244
Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Cyteir Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −6 vs. Q3 2022
- Shares held
- 17.3M
- −697.5K (−3.9%) vs. Q3 2022
- Total value
- $28.5M
- −$6.08M (−17.6%) vs. Q3 2022
- New holders
- 4
- 7 more added
- Sold out
- 10
- 12 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 4 | $11.2M |
| Q4 2023 | 38 | $38.9M |
| Q3 2023 | 41 | $46.3M |
| Q2 2023 | 39 | $41.7M |
| Q1 2023 | 32 | $23.9M |
| Q4 2022 | 30 | $28.5M |
| Q3 2022 | 37 | $34.6M |
| Q2 2022 | 45 | $56.8M |
| Q1 2022 | 52 | $83.8M |
| Q4 2021 | 48 | $253.4M |
| Q3 2021 | 38 | $344.1M |
| Q2 2021 | 33 | $352.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Cyteir Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 3 | $0 | 0.00% | +3 | New |
| Wells Fargo & Company | 97 | $160 | 0.00% | +3+3.2% | Added |
| Citigroup Inc | 246 | $406 | 0.00% | −423−63.2% | Reduced |
| JPMorgan Chase & Co | 496 | $1.00K | 0.00% | −1,536−75.6% | Reduced |
| Lindbrook Capital, LLC | 2,006 | $3.31K | 0.00% | 00.0% | Unchanged |
| International Assets Investment Management, LLC | 14,400 | $23.8K | 0.00% | +14,400 | New |
| Northern Trust Corp | 14,907 | $24.6K | 0.00% | +1,732+13.1% | Added |
| Cannell Capital LLC | 19,684 | $32.5K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 21,044 | $34.7K | 0.00% | +21,044 | New |
| State Street Corp | 23,853 | $39.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 24,817 | $40.9K | 0.00% | +3,810+18.1% | Added |
| Two Sigma Advisers, LP | 26,000 | $42.9K | 0.00% | −2,300−8.1% | Reduced |
| Ergoteles LLC | 30,148 | $49.7K | 0.00% | +30,148 | New |
| Morgan Stanley | 30,272 | $49.9K | 0.00% | −39,062−56.3% | Reduced |
| BlackRock Inc. | 79,344 | $130.9K | 0.00% | −117,568−59.7% | Reduced |
| Geode Capital Management, LLC | 117,132 | $193.0K | 0.00% | +3,504+3.1% | Added |
| Bridgeway Capital Management, LLC | 119,584 | $197.3K | 0.01% | 00.0% | Unchanged |
| Evercore Wealth Management, LLC | 146,676 | $242.0K | 0.01% | 00.0% | Unchanged |
| RBF Capital, LLC | 151,282 | $250.0K | 0.02% | −1,100−0.7% | Reduced |
| Millennium Management LLC | 179,366 | $296.0K | 0.00% | +60,132+50.4% | Added |
| Renaissance Technologies LLC | 229,193 | $378.0K | 0.00% | −37,628−14.1% | Reduced |
| Laurion Capital Management LP | 359,500 | $593.2K | 0.02% | 00.0% | Unchanged |
| Caas Capital Management LP | 459,779 | $758.6K | 0.15% | −157,043−25.5% | Reduced |
| Vanguard Group Inc | 584,783 | $964.9K | 0.00% | +2910.0% | Added |
| Newtyn Management, LLC | 1,020,000 | $1.68M | 0.35% | +365,888+55.9% | Added |
| Avidity Partners Management LP | 1,795,800 | $2.96M | 0.07% | −10,400−0.6% | Reduced |
| OUP Management Co., LLC | 2,459,572 | $4.06M | 6.63% | −10,000−0.4% | Reduced |
| Baker Bros. Advisors LP | 2,492,118 | $4.11M | 0.02% | −151,522−5.7% | Reduced |
| FMR LLC | 2,908,376 | $4.80M | 0.00% | −577,682−16.6% | Reduced |
| Novo Holdings A/S | 3,940,413 | $6.50M | 0.41% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −34,809−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −13,093−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −11,852−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −11,796−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −11,670−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,859−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −464−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −332−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |